COVID-19

Here's the roundup for this week's coronavirus-related news.

A new report from the National Academies of Sciences, Engineering, and Medicine include pharmacists in the priority group for receiving the COVID-19 vaccine when available.

Regeneron and Eli Lilly have both submitted applications seeking emergency use authorization for their investigational COVID-19 therapies.

MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” on Tuesday, October 13, 2020 at 6 PM EDT.

Here's the coronavirus-related news from this week that you should know.

Moderna’s COVID-19 mRNA vaccine candidate appears to induce as strong an immune response in older adults as in younger adults, according to an interim analysis.

Members of the MJH Life Sciences COVID-19 Coalition weighed in on the latest pandemic information in a recent survey.

Beth Mitchell, Senior Director, Government Affairs, AmerisourceBergen, explains how independent community pharmacists can effectively advocate on behalf of their pharmacy on the federal and state levels.

Approximately 1-third of parents who participated in a national survey said they are unlikely to have their child vaccinated against the flu amid the pandemic.

Investigators also reported a potential association between initial viral load and mortality in patients with COVID-19.

Here's this week's roundup of the coronavirus-related news you should know.

Tocilizumab (Actemra; Genentech) reduced the likelihood of needing mechanical ventilation in hospitalized patients with COVID-19 associated pneumonia.

The Assure test is the only FDA authorized COVID-19 point-of-care serology test.

Johnson & Johnson has launched its large-scale phase 3 trial for Janssen’s COVID-19 vaccine candidate.

A new report illuminates the similarities and differences between COVID-19 and seasonal influenza.

A study evaluated interference between rhinovirus and influenza A virus during the 2009 pandemic.

The study evaluated COVID-19 patients within the epicenter of the COVID-19 pandemic in the United States.

Here's this week's coronavirus-related news you should know.

The Trump administration released its COVID-19 vaccine strategy, with pharmacies among the list of suggested providers for distribution.

A study compared cardiac events associated with azithromycin versus amoxicillin.

Heidi Polek, strategic program manager at DrFirst, discusses with Drug Topics the impact that the COVID-19 pandemic is having on chronic conditions and medication adherence.

Early data from a phase 3 trial showed that baricitinib combined with remdesivir improved recovery in patients hospitalized with COVID-19 compared with remdesivir alone.

Survey responses indicated that almost 7 in 10 Americans are willing to get a COVID-19 vaccine when it becomes available.

After a temporary pause, investigators have received the green light to resume clinical trials for COVID-19 vaccine candidate AZD1222 following a safety review.

Here's this week's coronavirus-related news you should know.

In a partnership with top health care experts, MJH Life Sciences™ COVID-19 Coalition will host its inaugural event, "Battling Dual Threats: Flu and COVID-19 Converge" on Tuesday, September 15, at 6 p.m. EDT.

State-licensed pharmacists and pharmacy interns will be able to order and administer coronavirus disease 2019 vaccines under certain conditions.

Here's this week's coronavirus-related news.

AstraZeneca’s investigational coronavirus disease 2019 (COVID-19) vaccine candidate, AZD1222, has expanded into a phase 3 clinical trial.

A survey conducted by NCPA polled nearly 800 community pharmacy owners/managers on whether they plan to offer a COVID-19 vaccine in their pharmacies.